Intralesional Electrocoagulation With Insulated Microneedle for the Treatment of Periorbital Syringomas: A Retrospective Analysis

Aesthet Surg J. 2021 Mar 12;41(4):490-498. doi: 10.1093/asj/sjz288.

Abstract

Background: Conventional treatment options for periorbital syringomas are often unsatisfactory because of inevitable surface damage from the procedure and frequent recurrence rate of the tumors.

Objectives: The authors sought to ascertain the efficacy and safety of intralesional electrosurgery utilizing a monopolar radiofrequency device with a single insulated microneedle for the treatment of periorbital syringomas.

Methods: A retrospective analysis was performed employing data from medical records, routine questionnaires, and clinical photographs of 55 patients with periorbital syringoma who underwent intralesional electrosurgery.

Results: Approximately one-half of the patients (50.9%) experienced marked resolution after 1 treatment. The lesion clearance rate increased and lesion severity decreased each time the treatment was repeated. No persistent therapy-related adverse event was found except transient erythema or crusting.

Conclusions: Intralesional electrosurgery with insulated microneedle is an effective and safe treatment option for periorbital syringomas.

MeSH terms

  • Electrocoagulation / adverse effects
  • Humans
  • Neoplasm Recurrence, Local
  • Retrospective Studies
  • Sweat Gland Neoplasms* / surgery
  • Syringoma* / surgery